Medical device maker DexCom announced Tuesday that the company has received a de novo clearance from the FDA to sell its latest continuous glucose monitoring system — the G6 — that requires no ...
First-ever automated insulin delivery with the tubeless Omnipod Insulin Management System and personal smartphone control Initially compatible with Dexcom G6 CGM, with no fingersticks* required ...
San Diego’s Dexcom posted a 30 percent jump in revenue for the March quarter as it prepares for a major launch of its next generation continuous glucose monitors that no longer requires finger pricks ...
In addition to the G6, which will either require no fingerstick calibration or just one calibration at launch, depending on the company’s ultimate FDA strategy, Dexcom is planning to complete ...
Dexcom CGM use is proven to improve glycemic control 1,2 and can reduce the risk of costly long-term diabetes-related complications compared to fingerstick monitoring. 3 BURNABY, British ...
Please provide your email address to receive an email when new articles are posted on . The FDA on Tuesday approved the use of a professional continuous glucose monitoring system from Dexcom, ...
DexCom, Inc. DXCM recently announced that the Dexcom G6 continuous glucose monitoring (CGM) System has obtained CE Marking across Europe for attaching on the back of the upper arm, thereby offering ...
Life-changing CGM system indicated for persons age 2 years and older, now available for wear on back of the upper arm, giving patients more options EDINBURGH, Scotland, June 9, 2020 /PRNewswire/ -- ...
The Dexcom G6 iCGM system determines blood glucose levels in patients 2 years of age and older. The Food and Drug Administration (FDA) has authorized the marketing of the Dexcom G6 integrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback